ENMI - DH ENCHANTMENT, INC.
0.0001
0 0%
Share volume: 389
Last Updated: 02-19-2026
Wholesale/Wholesale – Drugs & Drug Proprietaries:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$0.00
0.00
0.00%
View ratios
| Fiscal Date | 09-30-2023 | 12-31-2023 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q2 2025 | Q3 2025 | |
| Report Date | 11-20-2023 | 02-20-2024 | 12-27-2024 | 02-19-2025 | |
| Total revenue | 442.994 K | 588.235 K | 361.387 K | 387.546 K | |
| Cost of revenue | 280.078 K | 455.746 K | 252.928 K | 255.543 K | |
| Gross profit | 162.916 K | 132.489 K | 108.459 K | 132.003 K | |
| -18.68% | -18.14% | 21.71% | |||
| Operating expenses | 27.073 K | 44.374 K | 369.125 K | 167.482 K | |
| Selling general and admin | 27.073 K | 44.374 K | 369.125 K | 167.482 K | |
| Research and development | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total expenses | 134.176 K | 145.062 K | 472.446 K | 214.782 K | |
| 8.11% | 225.69% | -54.54% | |||
| Operating income | 28.740 K | -12.573 K | -363.987 K | -82.779 K | |
| Ebit | 28.792 K | -10.203 K | -362.368 K | -82.766 K | |
| Pretax income | 6.189 K | -45.383 K | -410.304 K | -124.519 K | |
| -833.28% | 804.09% | -69.65% | |||
| Income tax | 1.697 K | -661.000 | -2.684 K | 363.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 4.492 K | -44.722 K | -407.620 K | -124.882 K | |
| -1,095.59% | -811.45% | 69.36% |